Related references
Note: Only part of the references are listed.Prognostic and predictive role of vascular endothelial growth factor polymorphisms in breast cancer
Angelos Koutras et al.
PHARMACOGENOMICS (2015)
Evaluation of thyroid cancer in Chinese females with breast cancer by vascular endothelial growth factor (VEGF), microvessel density, and contrast-enhanced ultrasound (CEUS)
Xi Wei et al.
TUMOR BIOLOGY (2014)
Validation study of the UICC TNM classification of malignant tumors, seventh edition, in breast cancer
Natsue Uehiro et al.
BREAST CANCER (2014)
Prognostic and Predictive Value of Tumor Vascular Endothelial Growth Factor Gene Amplification in Metastatic Breast Cancer Treated with Paclitaxel with and without Bevacizumab; Results from ECOG 2100 Trial
Bryan P. Schneider et al.
CLINICAL CANCER RESEARCH (2013)
The prognostic and predictive value of mRNA expression of vascular endothelial growth factor family members in breast cancer: a study in primary tumors of high-risk early breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial
Helena Linardou et al.
BREAST CANCER RESEARCH (2012)
HER-2 gene amplification correlates with higher levels of angiogenesis and lower levels of hypoxia in primary breast tumors
KL Blackwell et al.
CLINICAL CANCER RESEARCH (2004)
Correlation of vascular endothelial growth factor content with recurrences, survival, and first relapse site in primary node-positive breast carcinoma after adjuvant treatment
B Linderholm et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
